CLINICAL EFFICACY AND SAFETY OF LINEZOLID FOR THE TREATMENT OF EXTENSIVELY DRUG RESISTANT TUBERCULOSIS

被引：0
|
作者：
Yao, L. [1 ]
Tang, S-J [1 ]
Xiao, H-P [1 ]
Zeng, L-H [1 ]
Sun, H. [1 ]
Gu, J. [1 ]
Hao, X-H [1 ]
Liu, Y-D [1 ]
机构：
[1] Tongji Univ, Sch Med, Shanghai Key Lab TB, Dept TB,Shanghai Pulm Hosp, Shanghai 200092, Peoples R China
来源：
RESPIROLOGY | 2011年 / 16卷
关键词：
Mycobacterium tuberculosis; XDR-TB; Linezolid; Chemotherapy; Adverse effects;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [41] Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis
    Yew, Wing Wai
    Chang, Kwok Chiu
    Chau, Chi Hung
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (05) : 1119 - 1119
  • [42] Efficacy and safety of levamisole as an immunomodulator in the treatment of drug resistant tuberculosis
    Sarangdhar, Nikhil
    Mohanty, K. C.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [43] Simple strategy to assess linezolid exposure in patients with multi-drug-resistant and extensively-drug-resistant tuberculosis
    Kamp, Jasper
    Bolhuis, Mathieu S.
    Tiberi, Simon
    Akkerman, Onno W.
    Centis, Rosella
    de lange, Wiel C.
    Kosterink, Jos G.
    van der Werf, Tjip S.
    Migliori, Giovanni B.
    Alffenaar, Jan-Willem C.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (06) : 688 - 694
  • [44] Multidrug and Extensively Drug-resistant Tuberculosis Epidemiology, Clinical Features, Management and Treatment
    Tiberi, Simon
    Zumla, Alimuddin
    Migliori, Giovanni Battista
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2019, 33 (04) : 1063 - +
  • [45] Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment
    Keutzer, Lina
    Mockeliunas, Laurynas
    Sturkenboom, Marieke G. G.
    Bolhuis, Mathieu S.
    Akkerman, Onno W.
    Simonsson, Ulrika S. H.
    PHARMACEUTICALS, 2023, 16 (11)
  • [46] Linezolid in the treatment of multidrug-resistant/extensively drug-resistant tuberculosis in paediatric patients: Experience of a paediatric infectious diseases unit
    Kjoellerstroem, Paula
    Brito, Maria Joao
    Gouveia, Catarina
    Ferreira, Goncalo
    Varandas, Luis
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 43 (6-7) : 556 - 559
  • [47] Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
    Caminero, Jose A.
    Sotgiu, Giovanni
    Zumla, Alimuddin
    Migliori, Giovanni Battista
    LANCET INFECTIOUS DISEASES, 2010, 10 (09): : 621 - 629
  • [48] Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06
    Anger, Holly A.
    Dworkin, Felicia
    Sharma, Saarika
    Munsiff, Sonal S.
    Nilsen, Diana M.
    Ahuja, Shama D.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (04) : 775 - 783
  • [49] Treatment of extensively drug-resistant tuberculosis and role of the pharmacist
    Mitrzyk, Beatriz Manzor
    PHARMACOTHERAPY, 2008, 28 (10): : 1243 - 1254
  • [50] Validation of Cycloserine Efficacy in Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Beijing, China
    Yu, Xia
    Zeng, Xiling
    Shi, Wenhui
    Hu, Yanjie
    Nie, Wenjuan
    Chu, Naihui
    Huang, Hairong
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (03)
12345